Autopsy report · NCT00589602
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Cause of deathSlow enrollment
“slow accrual”
Life of this trial
- Registered 4 years after it had already started.
- Ran for about 10 years 11 months before it stopped.
- 13 participants enrolled.
- Results were posted on the registry 2 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- The Cleveland Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Malignant Plasma Cell Neoplasms; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition
- Interventions
- peripheral blood lymphocyte therapy; allogeneic hematopoietic stem cell transplantation; peripheral blood stem cell transplantation; total-body irradiation (TBI)
- Participants
- 13
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.